Antimicrobial Resistance in Acute Cholangitis
Exploring Antimicrobial Resistance in Patients With Acute Cholangitis Undergoing ERCP: A Prospective Multicentre Study
Emergency County Hospital Pius Brinzeu; Timisoara, Romania
1,700 participants
Jan 8, 2024
OBSERVATIONAL
Conditions
Summary
This study prospectively explores antimicrobial resistance in patients with acute cholangitis undergoing ERCP procedures. By analyzing patient profiles, microbial cultures, and treatment outcomes, the current study seeks to identify specific patterns of resistance, assess the effectiveness of current antimicrobial therapies, and explore potential strategies to optimize treatment regimens.
Eligibility
Inclusion Criteria4
- Patients with acute cholangitis
- Ability to provide an informed consent
- Age over 18 years
- Any gender
Exclusion Criteria6
- Age under 18
- Pregnancy
- Post-ERCP perforation
- The patient's decision to abstain from study enrollment
- Patients unable to express informed consent
- Patients from whom a bile sample could not be collected.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
ERCP will serve as the exclusive therapeutic modality, aided by a therapeutic duodenoscope to access the common bile duct using a guidewire.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06197984